NCT02901366View on ClinicalTrials.gov

Mass Balance Study of FYU-981

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

July 31, 2018

Conditions
Healthy Male Subjects
Interventions
DRUG

14C-FYU-981

14C-FYU-981, (Oral single dosing)

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
collaborator

Mochida Pharmaceutical Company, Ltd.

INDUSTRY

lead

Fuji Yakuhin Co., Ltd.

INDUSTRY